Thought Technology, Montreal, has entered a co-marketing agreement with Evoke Neuroscience that will allow customers to complement their biofeedback practice by assessing brain function with the eVox System, a medical device that enables primary and specialty care physicians to assess brain function in-office and use the results to aid in making clinical diagnoses.
Historically, most providers trying to diagnose neurologically based disorders have relied on self-report questionnaires and effort-based computerized testing. But to understand cognitive health and especially memory, it is important to measure key biomarkers of the brain itself. The eVox System delivers objective and stable biomarkers that can complement a doctor’s professional judgment in diagnosing cognitive diseases using an in-office, non-invasive procedure performed with minimal staff training and time.
Thought Technology’s instrumentation is designed to assess autonomic nervous system functioning by measuring EEG, hand temperature, skin conductance (GSR), sEMG, respiration and heart rate variability. It provides a window into how these processes are functioning, in real time. This information can be used to help clients not only observe how their bodies react to stress, but also to use Biofeedback to control their physiological processes for better health, a media release from Thought Technology explains.
“Our collaboration with Evoke Neuroscience will allow Thought Technology to expand its assessment and training solutions to customers who use their Quantitative EEG prior to trainings. We know the clinical training with our instrumentation guided by information derived from the eVox System will enable clinicians to see the full picture of their clients’ psychophysiological condition and train them to an optimal state.”
— Helen Mavros, Director of Sales and Marketing at Thought Technology
[Source(s): Thought Technology Ltd, PRWeb]